Upgrade to SI Premium - Free Trial

Nektar Therapeutics (NKTR) PT Raised to $140 at Oppenheimer

March 13, 2026 12:39 PM
Oppenheimer analyst Jay Olson raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $140.00 (from $115.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change